About the journal
Expert Opinion on Orphan Drugs is a journal published by Taylor & Francis in United Kingdom. It is listed in PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Taylor & Francis
- ISSN
- 2167-8707
- Country
- United Kingdom
- Access
- Not open access / not declared
- Declared peer-review model
- peer_review
- Official website
- https://www.tandfonline.com/toc/ieod20/current
Index listings
- PUBMED · 2013-10-01
- Indexing
- PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2024
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
862
Last recorded publication year
2024
h-index
34
i10-index
145
From OpenAlex open data (CC0).
Editorial & policy4
- Observed digital preservation (Keepers registry)— snapshot 2026-09-21
- CLOCKSSPortico
- Open references deposited at Crossref
- 100%
- ORCID iDs in current deposits
- 40%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity1
- Source type
- journal
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Lysosomal Storage Disorders Research
- Lysosomal Storage Disorders Research
- Genomics and Rare Diseases
- Genomics and Rare Diseases
- Health Systems, Economic Evaluations, Quality of Life
- Health Systems, Economic Evaluations, Quality of Life
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
Show all subjects (50)
- Diverse Scientific and Economic Studies
- Diverse Scientific and Economic Studies
- Human auditory perception and evaluation
- Human auditory perception and evaluation
- Educational Robotics and Engineering
- Chronic Lymphocytic Leukemia Research
- Neurogenetic and Muscular Disorders Research
- Neurogenetic and Muscular Disorders Research
- Chronic Lymphocytic Leukemia Research
- Educational Robotics and Engineering
- Pharmaceutical Economics and Policy
- Pharmaceutical Economics and Policy
- Cystic Fibrosis Research Advances
- Metabolism and Genetic Disorders
- Metabolism and Genetic Disorders
- Cystic Fibrosis Research Advances
- Trypanosoma species research and implications
- Acute Myeloid Leukemia Research
- Trypanosoma species research and implications
- Acute Myeloid Leukemia Research
- Mitochondrial Function and Pathology
- Muscle Physiology and Disorders
- Mitochondrial Function and Pathology
- Muscle Physiology and Disorders
- CRISPR and Genetic Engineering
- CRISPR and Genetic Engineering
- Sarcoma Diagnosis and Treatment
- Sarcoma Diagnosis and Treatment
- Platelet Disorders and Treatments
- Virus-based gene therapy research
- Platelet Disorders and Treatments
- Virus-based gene therapy research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- CAR-T cell therapy research
- Chronic Myeloid Leukemia Treatments
- CAR-T cell therapy research
- Glycogen Storage Diseases and Myoclonus
- Genetic Neurodegenerative Diseases
- Glycogen Storage Diseases and Myoclonus
- Genetic Neurodegenerative Diseases
- Chronic Myeloid Leukemia Treatments
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ